Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Biomarin Pharmaceutical Inc publishes a filing, an earnings call transcript or a press release.

Get BMRN alerts

About Kristen Hubbard

Kristen Hubbard has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Biomarin Pharmaceutical Inc on November 2, 2026. Biomarin Pharmaceutical Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Biomarin Pharmaceutical Inc includes Alexander Hardy (CEO and Board Member), Richard A. Meier (Chairman), Brian Mueller (CFO) and 7 others.

Kristen Hubbard on recent calls

“The third quarter, again, showed the strength and growing diversity of our portfolio. Our team stayed focused on expanding diagnosis, increasing access, and helping more patients start and stay on therapy.”
Other, BioMarin Pharmaceutical Third Quarter 2026 Conference Call ·
“And thank you so much for having us, Eric. So just to take a step back, Biomarin, we're a leading global rare disease company, and we're really focused in and around genetically defined conditions.”
Other, Citi's 2026 Biopharma Back to School Conference ·
“I'll open by highlighting the outstanding work of our teams around the world. Their focus and deep expertise have been instrumental in driving another year of impressive commercial performance.”
Other, Biomarin Pharmaceutical Inc Q4 FY2025 Earnings Call ·
“I want to begin by acknowledging the exceptional work from our teams across the world whose dedication has delivered strong year-to-date results for Biomarin's commercial portfolio.”
Other, Biomarin Pharmaceutical Inc Q3 FY2025 Earnings Call ·
“The team's focus on commercial execution led to another quarter of strong growth across the business. Starting with Voxogo for the treatment of achondroplasia, we were very pleased to have delivered 40% year-over-year revenue growth with strong contributions from across the globe.”
Other, Biomarin Pharmaceutical Inc Q1 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Biomarin Pharmaceutical Inc

Recent activity